MOTS-c vs NAD+: Two Mitochondrial Longevity Pathways Compared | QSC Research

QSC Research · Published 2025-02-01

MOTS-c vs NAD+: Two Mitochondrial Longevity Pathways Compared

MOTS-c and NAD+ both target mitochondrial function as a longevity mechanism — but through fundamentally different approaches. NAD+ repletes the electron carrier cofactor required for sirtuin and PARP activity. MOTS-c is a mitochondria-derived signalling peptide that activates AMPK/SIRT1 from a completely different angle. Understanding both allows researchers to study mitochondrial ageing from two independent mechanistic entry points.

⚡

NAD+ — The Cofactor Decline Model of Mitochondrial Ageing

NAD+ declines approximately 50% from young to aged mammalian tissue. This decline impairs:

Function NAD+-dependent enzyme Ageing consequence
Sirtuin deacetylation SIRT1/2/3/6 Reduced mitochondrial biogenesis (PGC-1a), impaired DNA repair, metabolic dysregulation
DNA repair PARP1/2 Accumulating DNA strand breaks — genomic instability
Redox (ETC) Complex I (NADH→NAD+) Impaired electron transport, ATP production deficiency
CD38 activity CD38 (NAD+-consuming) Age-related CD38 elevation consumes NAD+, worsening the cycle

NAD+ repletion strategies

NAD+ precursors (NMN, NR) or direct NAD+ repletion restore the cofactor pool — reactivating SIRT1/3 and PARP1. Direct NAD+ administration is the most immediate approach in cell culture. For in vivo, NMN or NR are more bioavailable due to cellular uptake pathways.

MOTS-c — Mitochondria-Derived Signalling Peptide

MOTS-c (21 amino acids, encoded in the 12S rRNA of mitochondrial DNA) is unique in the QSC catalog — the only compound encoded in the mitochondrial genome. Its mechanism:

Step Mechanism
Mitochondrial synthesis Encoded in mtDNA 12S rRNA — translated in mitochondria, not nucleus
Nuclear translocation Under metabolic stress, MOTS-c translocates from mitochondria to nucleus
AMPK activation MOTS-c activates AMPK (energy sensor) → downstream metabolic reprogramming
SIRT1/PGC-1a AMPK → SIRT1 deacetylation of PGC-1a → mitochondrial biogenesis
Insulin sensitisation GLUT4 translocation, improved glucose uptake — exercise mimetic effect

What makes MOTS-c unique as a research tool

MOTS-c is a retrograde signal — mitochondria communicating to the nucleus about their functional state. This makes it the only compound in the QSC catalog that directly studies mitochondria-to-nucleus signalling (retrograde communication). NAD+ addresses the substrate availability of mitochondrial enzymes; MOTS-c addresses mitochondrial-nuclear communication.

Direct Comparison for Research Design

Parameter MOTS-c NAD+
Origin Mitochondrial peptide (12S rRNA encoded) Dinucleotide — biosynthesised from tryptophan/nicotinamide
Primary target AMPK → SIRT1/PGC-1a (retrograde signal) SIRT1/3/PARP1/CD38 (substrate cofactor)
Mechanism of action Signalling peptide — activates enzyme cascades Cofactor — required substrate for enzymatic reactions
Ageing hallmark Deregulated nutrient sensing, mitochondrial dysfunction Mitochondrial dysfunction, genomic instability
Exercise mimetic? Yes — AMPK activation mimics exercise signalling Partial — NAD+/SIRT1 activated by exercise
Brain penetration Limited data — mostly peripheral Limited — but SIRT1 in neurons responsive to NAD+ precursors
Research standard Novel — emerging literature Well-established — 20+ years of sirtuin research

Combining MOTS-c and NAD+ in Longevity Research

The combination rationale:

  • NAD+ addresses the cofactor deficiency — restoring substrate for SIRT1/3
  • MOTS-c addresses the mitochondria-to-nucleus signalling deficiency — independently activating SIRT1 pathway via AMPK
  • Combination studies: measure SIRT1 activity, PGC-1a expression, mitochondrial biogenesis (mtDNA copy number, TFAM), ETC complex activity, ROS — with each compound alone and in combination

Protocol note

For aged C57BL/6 models: MOTS-c 5 mg/kg IP daily + NAD+ 500 mg/kg IP daily × 8-12 weeks. Primary endpoints: mtDNA copy number, SIRT1/SIRT3 activity (deacetylation assay), PGC-1a/TFAM/NRF1 expression, Seahorse mitochondrial respiration, plasma metabolic parameters, cognitive testing (Y-maze, rotarod).

❓

Frequently Asked Questions

What is MOTS-c?

MOTS-c is a 21 amino acid peptide encoded in the mitochondrial genome (12S rRNA region) — the only mitochondria-encoded signalling peptide identified to date. It translocates from mitochondria to nucleus under metabolic stress, activating AMPK and downstream SIRT1/PGC-1a signalling.

How does NAD+ decline relate to ageing?

NAD+ declines approximately 50% from young to aged tissue. This decline impairs SIRT1/2/3 deacetylase activity (required for mitochondrial biogenesis and DNA repair), PARP1 activity (DNA damage repair), and mitochondrial electron transport efficiency. NAD+ repletion reverses multiple ageing phenotypes in rodent models.

Can MOTS-c and NAD+ be combined?

Yes — they act through convergent but independent pathways. NAD+ restores the cofactor substrate for SIRT1; MOTS-c activates SIRT1 pathway via AMPK signalling from mitochondria. Combining them addresses both the substrate deficiency and the upstream signalling deficiency simultaneously.

USA · EU · UK · Canada · Australia
Research Use Only: All QSC compounds are sold strictly for laboratory research purposes. Not for human use.
Peptides
Orals
Oils
Search
Contact